Overview
Type 1 interferonopathy of childhood is a rare group of inherited immune system disorders that cause the body to produce too much of a protein called interferon. Interferon is normally made to fight viruses, but in these conditions the immune system stays switched on even when there is no infection. This constant activation causes widespread inflammation that can damage the brain, skin, joints, and other organs over time. Children with this condition may develop symptoms very early in life, sometimes even before birth. Common problems include brain inflammation, skin rashes that look like frostbite on the fingers and toes, joint swelling, and difficulty with movement and thinking. The condition is sometimes called a type I interferonopathy or childhood-onset interferonopathy, and it overlaps with conditions like Aicardi-Goutières syndrome and STING-associated vasculopathy with onset in infancy (SAVI). Treatment is focused on calming the overactive immune response. Doctors may use medications that block the interferon pathway, such as JAK inhibitors like ruxolitinib or baricitinib, though these are not yet formally approved specifically for this group of diseases. Supportive care, physical therapy, and regular monitoring are also important parts of management. Research is ongoing and the treatment landscape is improving.
Key symptoms:
Brain inflammation causing developmental delay or regressionSkin rashes resembling frostbite on fingers, toes, ears, and noseJoint pain and swellingMuscle stiffness or spasticitySeizuresIntellectual disability or learning difficultiesRecurrent fevers without infectionCalcium deposits in the brain visible on scansSmall head size (microcephaly)Fatigue and low energyLung inflammation causing breathing problems in some subtypesEye inflammation or vision problemsPoor growth and weight gain
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Type 1 interferonopathy of childhood.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Type 1 interferonopathy of childhood at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Type 1 interferonopathy of childhood.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Type 1 interferonopathy of childhood.
Community
No community posts yet. Be the first to share your experience with Type 1 interferonopathy of childhood.
Start the conversation →Latest news about Type 1 interferonopathy of childhood
No recent news articles for Type 1 interferonopathy of childhood.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene is causing my child's condition, and what does that mean for their prognosis?,Should my child start a JAK inhibitor, and what are the risks and benefits?,How often does my child need brain scans and other monitoring tests?,Are there any clinical trials my child might be eligible for?,What signs should prompt me to go to the emergency room?,Should other family members be tested for the same gene change?,What therapies, such as physical or speech therapy, would most benefit my child right now?
Common questions about Type 1 interferonopathy of childhood
What is Type 1 interferonopathy of childhood?
Type 1 interferonopathy of childhood is a rare group of inherited immune system disorders that cause the body to produce too much of a protein called interferon. Interferon is normally made to fight viruses, but in these conditions the immune system stays switched on even when there is no infection. This constant activation causes widespread inflammation that can damage the brain, skin, joints, and other organs over time. Children with this condition may develop symptoms very early in life, sometimes even before birth. Common problems include brain inflammation, skin rashes that look like fro
At what age does Type 1 interferonopathy of childhood typically begin?
Typical onset of Type 1 interferonopathy of childhood is infantile. Age of onset can vary across affected individuals.